Roche’s Virtual Early Drug Development gRED Event 2020 Webcast Replay

Roche has hosted a live video webcast on Tuesday, 18 February 2020.

For optimal viewing, please use Google Chrome


  • Welcome
    Karl Mahler, Head of Investor Relations and Roche Group Planning
  • Overview and Introduction to Genentech (gRED)
    Michael Varney, Head of Genentech Research and Early Development
  • Non-Oncology Pipeline Overview
    Andy Chan, Senior Vice President, Research Biology for gRED
  • Oncology Pipeline Overview
    Stuart Lutzker, Vice President, Oncology Research and ad interim Head of Early Clinical Development for gRED
  • Cancer Immunotherapy
    Ira Mellman, Vice President, Cancer Immunology and Immunology for gRED
  • Q&A

Please register to access the on-demand webcast.

* Mandatory


The registration form for the webcast is not available.


Please come back 30 minutes before the webcast start date and fill in the registration form.